FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211156771> ?p ?o ?g. }

• W4211156771 endingPage "1668" @default.
• W4211156771 startingPage "1659" @default.
• W4211156771 abstract "Stereotactic body radiation therapy (SBRT) for patients with borderline resectable and locally advanced pancreatic adenocarcinoma (BRPC/LAPC) remains controversial. Herein, we report on surgical, pathologic, and survival outcomes in BRPC/LAPC patients treated at a high-volume institution with induction chemotherapy (CTX) followed by 5-fraction SBRT.BRPC/LAPC patients treated between 2016 and 2019 were retrospectively reviewed. Surgical and pathological outcomes were descriptively characterized. Overall survival (OS) and progression-free survival (PFS) were analyzed using Cox proportional hazard regression. Locoregional failure and distant failure were analyzed with Fine-Gray competing risk model.Of 155 patients, 91 (59%) had LAPC and 64 (41%) had BRPC. Almost all were treated with induction multi-agent CTX with either FOLFIRINOX (75%) or gemcitabine and nab-paclitaxel (24%) for a median duration of 4.0 months (1-18 months). All received SBRT to a median dose of 33 Gy. Among 64 BRPC patients, 50 (78%) underwent resection, of whom 48 (96%) achieved margin-negative (R0) resection. Among 91 LAPC patients, 57 (63%) underwent resection, of whom 50 (88%) achieved R0 resection. Despite the high R0 rate, 33% of patients experienced locoregional failure, which was a component of 44% of all failures. After SBRT, median OS and PFS were 18.7 and 7.7 months, respectively. After SBRT, 1- and 2-year OS probabilities were 70% and 45%, whereas, from diagnosis, they were 93% and 51%.Although a high proportion of BRPC/LAPC patients treated with induction multi-agent CTX followed by SBRT successfully achieved R0 resection, locoregional failure remained common, highlighting the need to continue to optimize radiation delivery in this context." @default.
• W4211156771 created "2022-02-13" @default.
• W4211156771 creator A5006502149 @default.
• W4211156771 creator A5011776853 @default.
• W4211156771 creator A5014748431 @default.
• W4211156771 creator A5023417278 @default.
• W4211156771 creator A5026118399 @default.
• W4211156771 creator A5029871629 @default.
• W4211156771 creator A5030249492 @default.
• W4211156771 creator A5031382329 @default.
• W4211156771 creator A5033720986 @default.
• W4211156771 creator A5033904513 @default.
• W4211156771 creator A5038945187 @default.
• W4211156771 creator A5048788581 @default.
• W4211156771 creator A5051619233 @default.
• W4211156771 creator A5054307799 @default.
• W4211156771 creator A5060335470 @default.
• W4211156771 creator A5060529206 @default.
• W4211156771 creator A5068945817 @default.
• W4211156771 creator A5078198832 @default.
• W4211156771 creator A5089299130 @default.
• W4211156771 date "2022-02-10" @default.
• W4211156771 modified "2023-10-01" @default.
• W4211156771 title "High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy" @default.
• W4211156771 cites W1480172283 @default.
• W4211156771 cites W1894182878 @default.
• W4211156771 cites W1955000909 @default.
• W4211156771 cites W1968812902 @default.
• W4211156771 cites W1994447237 @default.
• W4211156771 cites W2012005360 @default.
• W4211156771 cites W2024709532 @default.
• W4211156771 cites W2045913019 @default.
• W4211156771 cites W2075276732 @default.
• W4211156771 cites W2099011347 @default.
• W4211156771 cites W2101345979 @default.
• W4211156771 cites W2103711657 @default.
• W4211156771 cites W2118797060 @default.
• W4211156771 cites W2121608920 @default.
• W4211156771 cites W2150881991 @default.
• W4211156771 cites W2172089182 @default.
• W4211156771 cites W2196287118 @default.
• W4211156771 cites W2294867706 @default.
• W4211156771 cites W2327072410 @default.
• W4211156771 cites W2346921980 @default.
• W4211156771 cites W2409856225 @default.
• W4211156771 cites W2529956502 @default.
• W4211156771 cites W2748131247 @default.
• W4211156771 cites W2752397106 @default.
• W4211156771 cites W2801077576 @default.
• W4211156771 cites W2801301689 @default.
• W4211156771 cites W2808370854 @default.
• W4211156771 cites W2891625981 @default.
• W4211156771 cites W2911188335 @default.
• W4211156771 cites W2912196744 @default.
• W4211156771 cites W2926499479 @default.
• W4211156771 cites W2932433038 @default.
• W4211156771 cites W2937476328 @default.
• W4211156771 cites W2986802285 @default.
• W4211156771 cites W3006013779 @default.
• W4211156771 cites W3047544401 @default.
• W4211156771 cites W3085058587 @default.
• W4211156771 cites W3110073091 @default.
• W4211156771 cites W3122184502 @default.
• W4211156771 cites W3126741775 @default.
• W4211156771 cites W3135350757 @default.
• W4211156771 cites W4211156771 @default.
• W4211156771 doi "https://doi.org/10.1002/cam4.4527" @default.
• W4211156771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35142085" @default.
• W4211156771 hasPublicationYear "2022" @default.
• W4211156771 type Work @default.
• W4211156771 citedByCount "10" @default.
• W4211156771 countsByYear W42111567712022 @default.
• W4211156771 countsByYear W42111567712023 @default.
• W4211156771 crossrefType "journal-article" @default.
• W4211156771 hasAuthorship W4211156771A5006502149 @default.
• W4211156771 hasAuthorship W4211156771A5011776853 @default.
• W4211156771 hasAuthorship W4211156771A5014748431 @default.
• W4211156771 hasAuthorship W4211156771A5023417278 @default.
• W4211156771 hasAuthorship W4211156771A5026118399 @default.
• W4211156771 hasAuthorship W4211156771A5029871629 @default.
• W4211156771 hasAuthorship W4211156771A5030249492 @default.
• W4211156771 hasAuthorship W4211156771A5031382329 @default.
• W4211156771 hasAuthorship W4211156771A5033720986 @default.
• W4211156771 hasAuthorship W4211156771A5033904513 @default.
• W4211156771 hasAuthorship W4211156771A5038945187 @default.
• W4211156771 hasAuthorship W4211156771A5048788581 @default.
• W4211156771 hasAuthorship W4211156771A5051619233 @default.
• W4211156771 hasAuthorship W4211156771A5054307799 @default.
• W4211156771 hasAuthorship W4211156771A5060335470 @default.
• W4211156771 hasAuthorship W4211156771A5060529206 @default.
• W4211156771 hasAuthorship W4211156771A5068945817 @default.
• W4211156771 hasAuthorship W4211156771A5078198832 @default.
• W4211156771 hasAuthorship W4211156771A5089299130 @default.
• W4211156771 hasBestOaLocation W42111567711 @default.
• W4211156771 hasConcept C121608353 @default.
• W4211156771 hasConcept C126322002 @default.
• W4211156771 hasConcept C126838900 @default.
• W4211156771 hasConcept C141071460 @default.

• next